Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Clearside Biomedical Inc (NASDAQ: CLSD) closed the day trading at $0.9 down -66.92% from the previous closing price of $2.72. In other words, the price has decreased by -$66.92 from its previous closing price. On the day, 5.11 million shares were traded. CLSD stock price reached its highest trading level at $1.0499 during the session, while it also had its lowest trading level at $0.8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 24 ’25 when Thorp Clay bought 15,000 shares for $0.92 per share. The transaction valued at 13,800 led to the insider holds 176,141 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 4710095 and an Enterprise Value of 59522060. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.41. Its current Enterprise Value per Revenue stands at 17.88 whereas that against EBITDA is -2.63.
Stock Price History:
The Beta on a monthly basis for CLSD is 1.88, which has changed by -0.8320988 over the last 52 weeks, in comparison to a change of 0.09654534 over the same period for the S&P500. Over the past 52 weeks, CLSD has reached a high of $17.10, while it has fallen to a 52-week low of $2.54. The 50-Day Moving Average of the stock is -76.25%, while the 200-Day Moving Average is calculated to be -90.28%.
Shares Statistics:
Over the past 3-months, CLSD traded about 51.45K shares per day on average, while over the past 10 days, CLSD traded about 44760 shares per day. A total of 5.23M shares are outstanding, with a floating share count of 4.17M. Insiders hold about 20.29% of the company’s shares, while institutions hold 12.59% stake in the company. Shares short for CLSD as of 1761868800 were 84559 with a Short Ratio of 1.64, compared to 1759190400 on 143266. Therefore, it implies a Short% of Shares Outstanding of 84559 and a Short% of Float of 1.6400000000000001.
Earnings Estimates
At present, 1.0 analysts are actively evaluating the performance of Clearside Biomedical Inc (CLSD) in the stock market.The consensus estimate for the next quarter is -$0.98, with high estimates of -$0.6 and low estimates of -$1.35.
Analysts are recommending an EPS of between -$2.7 and -$6.3 for the fiscal current year, implying an average EPS of -$4.85. EPS for the following year is -$4.9, with 6.0 analysts recommending between -$2.25 and -$7.2.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for CLSD’s current fiscal year. The highest revenue estimate was $2.8M, while the lowest revenue estimate was $2.8M, resulting in an average revenue estimate of $2.8M. In the same quarter a year ago, actual revenue was $1.66M
